GleamWall
中文EN

PSNL Personalis, Inc.

Services-Medical Laboratories · Nasdaq · SEC CIK 1527753 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY16.9%
TTM net income YoY-61.5%
TTM EPS YoY-39.8%
Revenue 3-yr CAGR4.6%
Net income 3-yr CAGR—

Margins

Gross margin16.7%
Operating margin-156.7%
Net margin-147.7%
FCF margin-133.3%
EBITDA margin-144.6%

Returns

ROE-62.1%
ROA-44.7%
ROIC (approx.)-84.8%
Asset turnover0.30x

Leverage & solvency

Liabilities / assets27.1%
Debt / equity0.00x
Current ratio4.53x
Interest coverage-683.98x

Cash quality & payout

Operating cash flow / net income0.82x
Accruals ratio-8.1%
Payout ratio—
Capex / revenue12.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$69.65M$84.61M
Cost of revenue$53.87M$57.79M
Gross profit$15.78M$26.82M
R&D expense$50.26M$48.91M
SG&A expense$53.57M$46.19M
Operating income-$88.06M-$68.27M
Interest expense$205,000$24,000
Pretax income-$81.25M-$81.27M
Income tax$21,000$18,000
Net income-$81.27M-$81.28M
EBITDA-$78.01M-$57.33M
EPS (basic)-0.91-1.37
EPS (diluted)-0.91-1.37
Weighted avg. shares (diluted)89.24M59.25M
Balance sheet
Cash & equivalents$124.25M$91.42M
Short-term investments$115.71M$93.59M
Receivables$16.20M$8.14M
Current assets$267.95M$203.01M
PP&E, net$44.81M$48.27M
Total assets$334.16M$270.27M
Current liabilities$39.63M$31.13M
Total liabilities$72.98M$67.31M
Shareholders' equity$261.19M$202.96M
Shares outstanding102.48M85.17M
Cash flow statement
Operating cash flow-$74.95M-$45.15M
Capital expenditure$4.50M$1.60M
Free cash flow-$79.45M-$46.75M
Investing cash flow-$22.57M-$35.07M
Financing cash flow$130.34M$114.67M
Depreciation & amortization$10.05M$10.94M
Stock-based compensation$9.43M$10.69M

Free plan shows the latest 2 periods; Pro shows all 9 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.